Cyclosporine Capsules, Modified and Ibritumomab
Determining the interaction of Cyclosporine Capsules, Modified and Ibritumomab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cyclosporine
Brand name: Gengraf, Neoral, Sandimmune, Sandimmune
Synonyms: Cyclosporine (oral/injection), CycloSPORINE (Systemic)
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cyclosporine Capsules, Modified-Ibritumomab Intravenous
- Cyclosporine Capsules, Modified-Ibritumomab Tiuxetan
- Cyclosporine Capsules, Modified-Ibrutinib
- Cyclosporine Capsules, Modified-Ibrutinib Capsules
- Cyclosporine Capsules, Modified-Ibrutinib Tablets
- Cyclosporine Capsules, Modified-Ibu
- Ibritumomab-Cyclosporine Injection
- Ibritumomab-Cyclosporine Oral Solution
- Ibritumomab-Cyclosporine Oral Solution, Modified
- Ibritumomab-Cyclosporine Oral, Intravenous
- Ibritumomab-Cyclosporine oral/injection
- Ibritumomab-Cyclosporine Soft Gelatin Capsules